4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000039
EVP Strategy and Corporate Dev sold 1,531 shares at an average $277.81 ($425,323)
From the SEC's structured data for this filing
Trades in this filing
Pacelli Steven Robert · EVP Strategy and Corporate Dev
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-24 | Sale : show line 1 in the form | −370 | $275.76 | $102,033 | 75,785 | D |
| 2020-02-24 | Sale : show line 2 in the form | −540 | $277.41 | $149,799 | 75,245 | D |
| 2020-02-24 | Sale : show line 3 in the form | −483 | $278.32 | $134,428 | 74,762 | D |
| 2020-02-24 | Sale : show line 4 in the form | −138 | $283.06 | $39,063 | 74,624 | D |
| Open-market sales · 1,531 sh · avg $277.81 · $425,323 | ||||||
Loading xslF345X03/edgardoc.xml…